Active Ingredient History
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. It is given by slow injection into a vein, typically at six- to eight-week intervals. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Aneurysm (Phase 1/Phase 2)
Anorexia (Phase 3)
Arthritis (Phase 2/Phase 3)
Arthritis, Juvenile (Phase 3)
Arthritis, Reactive (Phase 2)
Axial Spondyloarthritis (Phase 4)
Behcet Syndrome (Phase 3)
Berylliosis (Phase 1/Phase 2)
Biological Products (Phase 4)
Bipolar Disorder (Phase 2)
Breast Neoplasms (Phase 2)
Cachexia (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 2)
Child (Phase 4)
Choroidal Neovascularization (Phase 2)
Cogan Syndrome (Phase 2)
Colitis (Phase 3)
Corneal Diseases (Phase 1/Phase 2)
COVID-19 (Phase 4)
Cryoglobulinemia (Phase 2)
Cytokines (Phase 2)
Depression (Phase 4)
Depressive Disorder, Major (Phase 2)
Dermatomyositis (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Retinopathy (Phase 3)
Diagnostic Self Evaluation (Phase 1)
Drug Combinations (Phase 4)
Drug Evaluation (Phase 2)
Drug Monitoring (Phase 4)
Dyspepsia (Phase 4)
Endometriosis (Phase 2)
Enteral Nutrition (Phase 4)
Esophagitis (Phase 2)
Fatigue (Phase 3)
Fibrosis (Phase 3)
General Surgery (Phase 1/Phase 2)
Giant Cell Arteritis (Phase 2)
Graft vs Host Disease (Phase 4)
Granulomatosis with Polyangiitis (Phase 2)
Granulomatous Disease, Chronic (Phase 1/Phase 2)
Healthy Volunteers (Phase 1)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 3)
Hermanski-Pudlak Syndrome (Phase 2)
Hidradenitis Suppurativa (Phase 2)
Hypertension (Phase 4)
IgA Vasculitis (Phase 2)
Immune System Diseases (Phase 4)
Immunosuppression Therapy (Phase 4)
Inflammation (Phase 3)
Inflammatory Bowel Diseases (Phase 4)
Infliximab (Phase 4)
Insulin Resistance (Phase 4)
Intestinal Diseases (Phase 3)
Kidney Diseases (Phase 2)
Kidney Transplantation (Phase 2)
Low Back Pain (Phase 3)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 2/Phase 3)
Lupus Nephritis (Phase 2/Phase 3)
Lymphocytes (Phase 2)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 4)
Macular Degeneration (Phase 2)
Macular Edema (Phase 3)
Melanoma (Phase 2)
Membranes (Phase 1/Phase 2)
Mesalamine (Phase 4)
Metabolic Syndrome (Phase 4)
Methotrexate (Phase 4)
Microscopic Polyangiitis (Phase 2)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myositis (Phase 2/Phase 3)
Necrolytic Migratory Erythema (Phase 1/Phase 2)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 2)
Obesity (Phase 4)
Only Child (Phase 4)
Osteoarthritis, Knee (Phase 4)
Pancreatic Neoplasms (Phase 2)
Pancreatitis (Phase 2)
Paraparesis, Tropical Spastic (Phase 2)
Parapsoriasis (Phase 3)
Pemphigus (Phase 2)
Polyarteritis Nodosa (Phase 2)
Polychondritis, Relapsing (Phase 2)
Polymyalgia Rheumatica (Phase 3)
Polymyositis (Phase 2)
Psoriasis ()
Pulmonary Disease, Chronic Obstructive (Phase 3)
Radiation Pneumonitis (Phase 2)
Reperfusion Injury (Phase 2)
Retinal Detachment (Phase 2)
Retinal Diseases (Phase 2)
Sarcoidosis (Phase 3)
Schizophrenia (Phase 4)
Scleritis (Phase 2)
Self Efficacy (Phase 4)
Spondylarthropathies (Phase 4)
Spondylitis (Phase 4)
Steroids (Phase 4)
Stevens-Johnson Syndrome (Phase 2)
Stroke (Phase 1/Phase 2)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 2)
Thromboembolism (Phase 4)
Tumor Necrosis Factor-alpha (Phase 1/Phase 2)
Ultrasonography (Phase 4)
Uveitis (Phase 4)
Vasculitis (Phase 3)
Venous Cutdown (Phase 3)
Visual Acuity (Phase 3)
Vitreoretinopathy, Proliferative (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue